Lokelma is a prescription medication used to treat hyperkalemia, a condition where potassium levels in the blood are too high. It works by binding potassium in the gut and removing it through stool, helping bring levels back to a safe range. The FDA approved it specifically for adults, though it is not intended for emergency situations where dangerously high potassium requires immediate intervention.
Why High Potassium Needs Treatment
Potassium plays a critical role in how your heart and muscles function. When blood levels climb too high, typically above 5.0 mEq/L, the electrical signals that keep your heart beating in rhythm can become disrupted. Mild cases may cause no symptoms at all, while more severe hyperkalemia can trigger muscle weakness, numbness, nausea, or dangerous heart rhythm changes.
High potassium is especially common in people with chronic kidney disease, since the kidneys are responsible for filtering excess potassium out of the blood. It also shows up frequently in people taking certain blood pressure and heart failure medications (known as RAASi drugs) that raise potassium as a side effect. The challenge is that those medications are often essential for protecting the heart and kidneys, so doctors prefer to manage the potassium problem rather than stop the beneficial drug. That’s the gap Lokelma fills: it lets patients stay on their existing treatment regimen while keeping potassium in check.
How Lokelma Works
Lokelma is an inorganic crystal, not a traditional drug that gets absorbed into your bloodstream. It passes through the entire digestive tract and acts like a selective trap for potassium ions. As it moves through the gut, it exchanges sodium and hydrogen ions for potassium, locking the potassium into its crystal structure so it gets carried out of the body in stool. Because the compound is insoluble, highly stable, and never absorbed, it does its job entirely within the GI tract.
There’s also evidence that Lokelma binds ammonium ions produced by gut bacteria, which may have secondary effects on acid balance in the body. But its primary, FDA-approved purpose is straightforward potassium removal.
How Quickly It Works
Potassium levels start dropping within one hour of the first dose. In clinical trials, 84% of patients reached normal potassium levels within 24 hours, and 98% reached normal levels within 48 hours on the standard starting dose. By 72 hours, 99% of patients had achieved a potassium reading between 3.5 and 5.0 mEq/L.
That said, the reduction is gradual enough that Lokelma is not appropriate for life-threatening hyperkalemia, where potassium is high enough to cause immediate cardiac danger. Those situations require faster-acting emergency treatments, typically given intravenously in a hospital.
Dosing: Initial and Maintenance Phases
Lokelma comes as a powder that you mix with water and drink. Treatment happens in two phases. During the initial correction phase, the standard dose is 10 grams taken three times a day for up to 48 hours. This rapid schedule brings potassium down quickly.
Once levels normalize, you transition to a maintenance phase: 10 grams once daily, with adjustments ranging from as little as 5 grams every other day up to 15 grams daily depending on how your potassium responds. For people on chronic hemodialysis, the starting maintenance dose is typically 5 grams once daily on non-dialysis days, with higher starting doses considered if potassium is above 6.5 mEq/L.
How Well It Works Long Term
In the HARMONIZE trial, patients taking Lokelma maintained significantly lower potassium levels over a four-week period compared to placebo. Those on the 10-gram dose averaged 4.5 mEq/L, and those on 15 grams averaged 4.4 mEq/L, both well within the normal range. The placebo group averaged 5.1 mEq/L, which is at the upper boundary of normal.
Current guidelines from the international kidney disease organization KDIGO recommend newer potassium binders like Lokelma as a strategy for keeping patients with chronic kidney disease on their optimal heart and kidney medications. Rather than reducing the dose of a beneficial drug or restricting dietary potassium, the preferred approach is to add a potassium binder and maintain the rest of the treatment plan.
Side Effects
The most common side effect is swelling (edema), and it follows a dose-dependent pattern. In controlled trials lasting up to 28 days, edema occurred in 4.4% of patients on the 5-gram dose, 5.9% on 10 grams, and 16.1% on 15 grams, compared to 2.4% on placebo. In longer-term use where most patients stayed below 15 grams daily, edema rates ranged from 8% to 11%.
The other notable risk is that Lokelma can work too well. About 4.1% of patients in clinical trials developed low potassium (below 3.5 mEq/L), which resolved when the dose was reduced or the medication was stopped. This is why ongoing blood work to monitor potassium levels is a routine part of treatment.
Drug Interactions and Timing
Because Lokelma temporarily raises the pH in your stomach, it can interfere with how other medications are absorbed. Some drugs dissolve better in an acidic environment, and others dissolve better in a less acidic one. In practice, this means certain common medications like the blood thinner dabigatran may be absorbed less effectively when taken alongside Lokelma, while others like the cholesterol drug atorvastatin or the diuretic furosemide may be absorbed in higher amounts than expected.
The simple rule is to take other oral medications at least two hours before or two hours after your Lokelma dose. This spacing gives your stomach pH time to return to normal, so your other drugs absorb the way they’re supposed to.